Johnson B - Search Results

1

Unrelated donor α/β T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemia.

Leahy AB, Li Y, Talano JA, Elgarten CW, Seif AE, Wang Y, Johnson B, Monos DS, Kadauke S, Olson TS, Freedman J, Wray L, Grupp SA, Bunin N. Leahy AB, et al. Among authors: johnson b. Blood Adv. 2022 Feb 22;6(4):1175-1185. doi: 10.1182/bloodadvances.2021005492. Blood Adv. 2022. PMID: 34872106 Free PMC article.

2

Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease.

Johnson BD, Truitt RL. Johnson BD, et al. Blood. 1995 Jun 1;85(11):3302-12. Blood. 1995. PMID: 7756664 Free article.

3

The graft-versus-leukemia effect of post-transplant donor leukocyte infusion.

Johnson BD, Hanke CA, Truitt RL. Johnson BD, et al. Leuk Lymphoma. 1996 Sep;23(1-2):1-9. doi: 10.3109/10428199609054795. Leuk Lymphoma. 1996. PMID: 9021679 Review.

4

Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.

Johnson BD, Becker EE, Truitt RL. Johnson BD, et al. Biol Blood Marrow Transplant. 1999;5(3):123-32. doi: 10.1053/bbmt.1999.v5.pm10392958. Biol Blood Marrow Transplant. 1999. PMID: 10392958 Free article.

5

Photochemical treatment of donor lymphocytes inhibited their ability to facilitate donor engraftment or increase donor chimerism after nonmyeloablative conditioning or establishment of mixed chimerism.

Johnson BD, Taylor PA, Stankowski MC, Talib S, Hearst JE, Blazar BR. Johnson BD, et al. Biol Blood Marrow Transplant. 2002;8(11):581-7. doi: 10.1053/bbmt.2002.v8.abbmt080581. Biol Blood Marrow Transplant. 2002. PMID: 12463476

6

Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host disease.

Xia G, Kovochich M, Truitt RL, Johnson BD. Xia G, et al. Biol Blood Marrow Transplant. 2004 Nov;10(11):748-60. doi: 10.1016/j.bbmt.2004.07.004. Biol Blood Marrow Transplant. 2004. PMID: 15505606 Free article.

7

Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.

Xia G, Truitt RL, Johnson BD. Xia G, et al. Biol Blood Marrow Transplant. 2006 Apr;12(4):397-407. doi: 10.1016/j.bbmt.2005.11.519. Biol Blood Marrow Transplant. 2006. PMID: 16545723 Free article.

8

Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease.

Chen X, Vodanovic-Jankovic S, Johnson B, Keller M, Komorowski R, Drobyski WR. Chen X, et al. Among authors: johnson b. Blood. 2007 Nov 15;110(10):3804-13. doi: 10.1182/blood-2007-05-091074. Epub 2007 Aug 10. Blood. 2007. PMID: 17693581 Free PMC article.

9

Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory.

Jing W, Gershan JA, Johnson BD. Jing W, et al. Blood. 2009 Apr 30;113(18):4449-57. doi: 10.1182/blood-2008-11-190827. Epub 2009 Jan 30. Blood. 2009. PMID: 19182203 Free PMC article.

10

Depletion of CD25⁺ T cells from hematopoietic stem cell grafts increases posttransplantation vaccine-induced immunity to neuroblastoma.

Jing W, Yan X, Hallett WH, Gershan JA, Johnson BD. Jing W, et al. Blood. 2011 Jun 23;117(25):6952-62. doi: 10.1182/blood-2010-12-326108. Epub 2011 Apr 26. Blood. 2011. PMID: 21521781 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,830 results

Search Page

Filters